EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 14 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,936 | +96.8% | 400 | +101.0% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 199 | -75.1% | 0.00% | – |
| Q1 2022 | $8,000 | +300.0% | 799 | +301.5% | 0.00% | – |
| Q4 2021 | $2,000 | -85.7% | 199 | -85.9% | 0.00% | – |
| Q3 2021 | $14,000 | 0.0% | 1,408 | +2.2% | 0.00% | – |
| Q2 2021 | $14,000 | -48.1% | 1,378 | -48.5% | 0.00% | – |
| Q1 2021 | $27,000 | +42.1% | 2,678 | +53.2% | 0.00% | – |
| Q4 2020 | $19,000 | – | 1,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 248,674 | $2,578,749 | 1.28% |
| Verition Fund Management LLC | 397,603 | $4,115,191 | 0.06% |
| CLEAR STREET LLC | 2,740 | $28 | 0.00% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1 | $10 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |